Mineralys Therapeutics Ownership 2024 | Who Owns Mineralys Therapeutics Now?


OverviewForecastFinancialsChartTranscripts

Institutional Ownership

100.00%

Insider Ownership

2.55%

Retail Ownership

-2.55%

Institutional Holders

67.00

Mineralys Therapeutics Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
Tema ETF Trust1.25%55,80637,335202.13%Feb 29, 2024
PRUDENTIAL SECTOR FUNDS, INC.0.12%242,942--Feb 29, 2024
AMERICAN CENTURY MUTUAL FUNDS, INC.0.06%626,053242,33463.15%Jan 31, 2024
FRANKLIN STRATEGIC SERIES0.03%279,548135,94894.67%Jan 31, 2024
FIDELITY ADVISOR SERIES VII0.02%206,422--Jan 31, 2024
VANGUARD VALLEY FORGE FUNDS0.02%11,523--Mar 31, 2024
ETFis Series Trust I0.01%9,9473,74260.31%Jan 31, 2024
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.01%3,031--Mar 31, 2024
QUANTITATIVE MASTER SERIES LLC0.00%24,073--Mar 31, 2024
DRIEHAUS MUTUAL FUNDS0.00%33,920--Mar 28, 2024
FIDELITY SECURITIES FUND0.00%280,824--Jan 31, 2024
VANGUARD INDEX FUNDS0.00%852,912-159,883-15.79%Mar 31, 2024
SCHWAB CAPITAL TRUST0.00%50,15913,20635.74%Jan 31, 2024
Calvert Variable Products, Inc.0.00%1,87290092.59%Mar 31, 2024
Managed Portfolio Series0.00%12,596--Jan 31, 2024
Principal Exchange-Traded Funds0.00%6,002-381-5.97%Mar 31, 2024
FIDELITY SELECT PORTFOLIOS0.00%29,900--Feb 29, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%12,000-895-6.94%Mar 31, 2024
AMERICAN CENTURY STRATEGIC ASSET ALLOCATIONS INC0.00%5,0721,23132.05%Jan 31, 2024
VANGUARD VARIABLE INSURANCE FUNDS0.00%17,500--Mar 31, 2024
Federated Hermes Global Allocation Fund0.00%3,224--Feb 29, 2024
Federated Hermes Equity Funds0.00%6,000-14,000-70.00%Mar 31, 2024
RBB FUND, INC.0.00%19,925--Feb 29, 2024
Voya VARIABLE PORTFOLIOS INC0.00%6,450-1,097-14.54%Mar 31, 2024
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC0.00%855--Mar 31, 2024
Global X Funds0.00%5,236--Jan 31, 2024
STATE STREET INSTITUTIONAL INVESTMENT TRUST0.00%6,200-4,000-39.22%Mar 31, 2024
TIAA-CREF LIFE FUNDS0.00%215--Mar 31, 2024
NORTHERN FUNDS0.00%7,831-1,429-15.43%Mar 28, 2024
T. Rowe Price Index Trust, Inc.0.00%1,201--Mar 31, 2024
iSHARES TRUST0.00%803,365-54,797-6.39%Mar 31, 2024
EQ ADVISORS TRUST0.00%48,590-33-0.07%Mar 31, 2024
TRUST FOR PROFESSIONAL MANAGERS0.00%10,10310,103-Feb 29, 2024
Fidelity Rutland Square Trust II0.00%38,040--Feb 29, 2024
RYDEX SERIES FUNDS0.00%127--Dec 31, 2023
ALLSPRING MASTER TRUST0.00%1,663--Feb 29, 2024
RUSSELL INVESTMENT CO0.00%7,456--Jan 31, 2024
NATIONWIDE VARIABLE INSURANCE TRUST0.00%3,270--Mar 31, 2024
RYDEX DYNAMIC FUNDS0.00%63--Dec 31, 2023
PENN SERIES FUNDS INC0.00%400--Mar 28, 2024
ProFunds0.00%151-12-7.36%Mar 31, 2024
USAA MUTUAL FUNDS TRUST0.00%2,52646122.32%Jan 31, 2024
NATIONWIDE MUTUAL FUNDS0.00%1,327503.92%Jan 31, 2024
TIAA-CREF FUNDS0.00%27,5488,60845.45%Jan 31, 2024
Brighthouse Funds Trust II0.00%7,262--Mar 31, 2024
RYDEX VARIABLE TRUST0.00%8--Dec 31, 2023
COLLEGE RETIREMENT EQUITIES FUND0.00%7,068--Mar 31, 2024
Bridge Builder Trust0.00%29,8853101.05%Mar 31, 2024
SUNAMERICA SERIES TRUST0.00%2,20161438.69%Jan 31, 2024
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST0.00%11,700--Mar 31, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST0.00%9,676-1,838-15.96%Mar 31, 2024
FIDELITY SALEM STREET TRUST0.00%13,144440.34%Mar 31, 2024
PACIFIC SELECT FUND0.00%8,374-295-3.40%Mar 31, 2024
Advisors' Inner Circle Fund III0.00%5555-Jan 31, 2024
BlackRock Variable Series Funds, Inc.0.00%2,022--Mar 31, 2024
PRINCIPAL FUNDS, INC.0.00%2,28347826.48%Jan 31, 2024

Mineralys Therapeutics's largest mutual fund holder by % of total assets is "Tema ETF Trust", owning 55.81K shares, compromising 1.25% of its total assets.

Mineralys Therapeutics Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
31 Mar, 2367-

As of 31 Mar 23, 67 institutions are holding Mineralys Therapeutics's shares, representing an increase of 0.00% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Mar, 2324,614,925-

Mineralys Therapeutics (MLYS) has 24.61M shares outstanding as of 31 Mar 23, up 0.00% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Mar, 23100.00%-

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Mar, 23--

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Mar, 23--

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Mar, 2367-24,614,925-100.00%-----

Mineralys Therapeutics Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jul 26, 2024Slingsby Brian Taylordirector, 10 percent owner S-SaleSell550,000$13.05$7.18M8,644,579
Jul 18, 2024Rodman David Malcomofficer Chief Medical OfficerS-SaleSell525$15.00$7.88K102,873
Jul 12, 2024Levy Adam Scottofficer CFO and SecretaryS-SaleSell10,757$13.14$141.39K247,611
Jul 12, 2024Congleton Jondirector, officer Chief Executive OfficerS-SaleSell15,746$13.34$210.08K911,212
Jun 20, 2024Congleton Jondirector, officer Chief Executive OfficerS-SaleSell17,766$12.25$217.71K958,505
Jun 20, 2024Congleton Jondirector, officer Chief Executive OfficerS-SaleSell16,607$11.99$199.07K941,898
Jun 20, 2024Congleton Jondirector, officer Chief Executive OfficerS-SaleSell14,940$11.73$175.24K926,958
Jun 14, 2024Congleton Jondirector, officer Chief Executive OfficerS-SaleSell16,607$12.77$212.01K1,032,461

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Aug 13, 2024Rodman David Malcomofficer Chief Medical OfficerM-ExemptSell6,348$1.08$6.86K177,135
Aug 13, 2024Rodman David Malcomofficer Chief Medical OfficerM-ExemptSell5,017$0.54$2.71K25,087
Jul 26, 2024Slingsby Brian Taylordirector, 10 percent owner S-SaleSell550,000$13.05$7.18M8,644,579
Jul 18, 2024Rodman David Malcomofficer Chief Medical OfficerM-ExemptSell525$1.08$567.00183,483
Jul 18, 2024Rodman David Malcomofficer Chief Medical OfficerS-SaleSell525$15.00$7.88K102,873
Jul 12, 2024Rodman David Malcomofficer Chief Medical OfficerM-ExemptSell6,349$1.08$6.86K184,008
Jul 12, 2024Rodman David Malcomofficer Chief Medical OfficerM-ExemptSell5,017$0.54$2.71K30,104
Jul 12, 2024Levy Adam Scottofficer CFO and SecretaryS-SaleSell10,757$13.14$141.39K247,611
Jul 12, 2024Congleton Jondirector, officer Chief Executive OfficerS-SaleSell15,746$13.34$210.08K911,212
Jun 20, 2024Congleton Jondirector, officer Chief Executive OfficerS-SaleSell17,766$12.25$217.71K958,505
Jun 20, 2024Congleton Jondirector, officer Chief Executive OfficerS-SaleSell16,607$11.99$199.07K941,898
Jun 20, 2024Congleton Jondirector, officer Chief Executive OfficerS-SaleSell14,940$11.73$175.24K926,958
Jun 14, 2024Congleton Jondirector, officer Chief Executive OfficerS-SaleSell16,607$12.77$212.01K1,032,461

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Aug 13, 2024Rodman David Malcomofficer Chief Medical OfficerM-ExemptSell6,348$1.08$6.86K177,135
Aug 13, 2024Rodman David Malcomofficer Chief Medical OfficerM-ExemptBuy6,348$1.08$6.86K114,238
Aug 13, 2024Rodman David Malcomofficer Chief Medical OfficerM-ExemptBuy5,017$0.54$2.71K107,890
Aug 13, 2024Rodman David Malcomofficer Chief Medical OfficerM-ExemptSell5,017$0.54$2.71K25,087
Jul 26, 2024Slingsby Brian Taylordirector, 10 percent owner S-SaleSell550,000$13.05$7.18M8,644,579
Jul 18, 2024Rodman David Malcomofficer Chief Medical OfficerM-ExemptSell525$1.08$567.00183,483
Jul 18, 2024Rodman David Malcomofficer Chief Medical OfficerM-ExemptBuy525$1.08$567.00103,398
Jul 18, 2024Rodman David Malcomofficer Chief Medical OfficerS-SaleSell525$15.00$7.88K102,873
Jul 12, 2024Rodman David Malcomofficer Chief Medical OfficerM-ExemptSell6,349$1.08$6.86K184,008
Jul 12, 2024Rodman David Malcomofficer Chief Medical OfficerM-ExemptBuy6,349$1.08$6.86K102,873
Jul 12, 2024Rodman David Malcomofficer Chief Medical OfficerM-ExemptBuy5,017$0.54$2.71K96,524
Jul 12, 2024Rodman David Malcomofficer Chief Medical OfficerM-ExemptSell5,017$0.54$2.71K30,104
Jul 12, 2024Levy Adam Scottofficer CFO and SecretaryS-SaleSell10,757$13.14$141.39K247,611
Jul 12, 2024Congleton Jondirector, officer Chief Executive OfficerS-SaleSell15,746$13.34$210.08K911,212
Jun 20, 2024Congleton Jondirector, officer Chief Executive OfficerS-SaleSell17,766$12.25$217.71K958,505
Jun 20, 2024Congleton Jondirector, officer Chief Executive OfficerS-SaleSell16,607$11.99$199.07K941,898
Jun 20, 2024Congleton Jondirector, officer Chief Executive OfficerS-SaleSell14,940$11.73$175.24K926,958
Jun 17, 2024Gold Alexander Mdirector-A-AwardBuy44,000$12.69$558.36K44,000
Jun 17, 2024Gold Alexander Mdirector Buy----
Jun 14, 2024Congleton Jondirector, officer Chief Executive OfficerS-SaleSell16,607$12.77$212.01K1,032,461

The last insider sell of Mineralys Therapeutics's stock was made by Rodman David Malcom on Aug 13 2024, selling 6,348 shares at $1.08 per share (valued at $6.86K).

Mineralys Therapeutics Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 20245955.56%
Q2 20241515100.00%
Q1 2024136216.67%
Q4 202343133.33%
Q3 202397128.57%
Q1 2023117157.14%

5 total buy trades, and 9 total sell trades (buy/sell ratio of 0.56%) were made by Mineralys Therapeutics's insiders, as of Q3 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 2024-4-
Q2 2024-8-
Q1 20241--
Q4 20231--
Q3 202332150.00%
Q1 20233--

As of Q3 2024, Insider owners conducted 0 open market buy trades and 4 open market sell trades of Mineralys Therapeutics's stocks.

MLYS Ownership FAQ


Mineralys Therapeutics is owned by institutional shareholders (100.00%), insiders (2.55%), and public (-2.55%). The largest institutional shareholder of Mineralys Therapeutics is (0% of total shares) and the top mutual fund owner is Tema ETF Trust (1.25% of total shares).

As of Mar 2023, there are 67 institutional shareholders of Mineralys Therapeutics.